Inactivated Vaccine Market - Size, Share, Outlook, and Forecast till 2026

A vaccine that consists of virus particles, bacteria or other pathogens, which were grown in culture and then killed using heat or formaldehyde is called as inactivated vaccine or killed vaccine. The infectivity is reduced, as pathogens for inactivated vaccines are grown under controlled conditions and are killed. Inactivated vaccines are classified into whole virus vaccines, split virus vaccines, and subunit vaccines based on the method of inactivation of virus.

Increasing demand for inactivated vaccines from governments of industrialized and emerging economies is one of the major factors that is expected to drive growth of the global inactivated vaccines market over the forecast period. Moreover, advantages of inactivated vaccines such as safety, stability, and lack of chances of pathogen reactivation over live attenuated vaccines are expected to fuel growth of the global inactivated vaccines market during the forecast period. Rising prevalence of infectious diseases and increasing awareness among people about immunization are other factors propelling the market growth.

However, stringent government regulations and lack of supply of vaccines in remote areas are major factors that are expected to restrain growth of the global inactivated vaccines market.

Key Developments in Inactivated Vaccine Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the inactivated vaccine market. In 2017, Seqirus, a leading innovator in influenza vaccines and pandemic preparedness, announced its next major advancement in the use of cell-based influenza vaccine technology at its state-of-the art manufacturing facility in Holly Springs, North Carolina.

Moreover, in August 2017, Seqirus launched a new influenza vaccine called FLUAD 1, which is an adjuvanted trivalent influenza vaccine (aTIV) developed to address the burden of influenza in adults aged 65 years and over.

In March 2018, Sanofi completed the acquisition of Bioverativ Inc, a global biotechnology company. Also, Fluzone QIV HD (Quadrivalent Inactivated Influenza Vaccine - High Dose) by Sanofi is currently in phase 111 clinical trial.

Some of the major players operating in the global inactivated vaccine market include Emergent BioSolutions, GlaxoSmithKline plc, Merck & Co., Inc., Seqirus, Sanofi, Valneva SE, Pfizer Inc., and Bharat Biotech among others.

Global Human Vaccine Adjuvants Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Human Vaccine Adjuvants in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manuf...

Global Peptide Cancer Vaccine Market Research Report 2017

Published Date : Oct 2017

In this report, the global Peptide Cancer Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, co...

Asia-Pacific Pneumococcal Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Published Date : Oct 2017

"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines. 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vacc...

Asia-Pacific Vaccine Conjugate Market Report 2017

Published Date : Sep 2017

In this report, the Asia-Pacific Vaccine Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (...

Global Human Vaccine Market Research Report 2018

Published Date : Jul 2018

Human Vaccine Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany,...

Global HPV Vaccine Market Research Report 2018

Published Date : Jun 2018

HPV Vaccine Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, u...

Global Vaccine Technologies Market Research Report 2018

Published Date : Jun 2018

Vaccine Technologies Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, G...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vaccine Refrigerator Market 2018, Forecast to 2023

Published Date : Jul 2018

A vaccine refrigerator is a refrigeration unit designed specifically for storing vaccines and other temperature-sensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradati...

Global Vaccine Refrigerator Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Published Date : Jul 2018

A vaccine refrigerator is a refrigeration unit designed specifically for storing vaccines and other temperature-sensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradati...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pertussis Vaccine Market 2018, Forecast to 2023

Published Date : Jul 2018

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71-85% effective. Scope of the Report: This report focuses on the...

 

Select Licence :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.